Results: Using a BRET assay to detect receptor-G protein complexes, we find that constitutive activation causes a uniform reduction of the apparent efficacy of all ligands.
constitutive activation results from a lessened intrinsic barrier that restrains spontaneous coupling. Any ligand regardless of its efficacy must enhance this constraint to stabilize the ligand-bound complexed form. ───────────────────────────── Mutant and occasionally wild-type forms of G protein coupled receptors (GPCRs) can exist in a state of constitutive (ligand-independent) activation. Some ligands show "negative efficacy" in reversing this spontaneously active state and are thus named inverse agonists or negative antagonists (1) (2) (3) (4) . Unraveling the mechanisms of constitutive activity is important for the understanding of receptors functional chemistry (5) and may suggest novel therapeutic interventions for several genetic diseases associated with naturally occurring constitutively active receptor mutations (6) (7) (8) (9) (10) (11) (12) . Constitutive activation and inverse agonism are quantitatively predictable on the basis of the theoretical background that describes the cooperative effects between two ligand binding processes (i.e. the ligand and the G subunit) taking place on distinct sites of the same protein (i.e. the receptor) (13) (14) (15) (16) (17) (18) . However, little additional progress has been made in unraveling the mechanism and the structure-activity relationships that underlie the phenomenon of receptor constitutive activation. At least two factors hamper progress in the field. One is the difficulty to quantify the extent of ligandindependent activity. Constitutive activation can be assessed as difference in basal signaling between cells expressing or not the receptor. The magnitude of this "transfection-dependent" signaling is very small, often at the lowest limit of signal detection, and requires subtracting two larger numbers (i.e., the "basal" signaling recorded in two different cell populations). Thus, quantitative biochemical assessment of negative efficacy is difficult to accomplish and varies widely across different studies.
The second problem is the rare availability of ligand congeners exhibiting gradual variations from positive to negative values of efficacy. Even when several inverse agonists are known for a given GPCR subtype, they often belong to a different chemical class than the agonist or the neutral antagonist. Thus, it is hard to evaluate how discrete modifications of structure may tune the transition from the positive to the negative region of efficacy (19) .
Here we used a cell-free bioluminescence resonance energy transfer (BRET) assay of receptor-G protein interaction to measure intrinsic and ligand-dependent coupling. In this system receptor binding to endogenous G subunits results in reduced distance between the receptor C-terminal and the N-terminal region of the G  subunit. This causes enhanced RET emission between a bioluminescent (Rluc) donor and a fluorescent (RGFP) acceptor that are genetically tethered to the respective endings of the two molecules (20) (21) (22) . Binding of guanine nucleotide to endogenous G subunits abolishes the signal, thus allowing measuring the extent of constitutive activation as the difference in basal signal between absence and presence of GDP. We evaluated the differences in spontaneous and ligand-regulated coupling between  (MOP) and  (DOP) opioid receptors (23,24), using 35 analogues sharing a common peptidomimetic scaffold. This is derived from the condensation of the two unnatural amino acids, 2',6'-dimethyltyrosine (Dmt) and 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid (Tic). As previously shown, substitutions within the Dmt-Tic pharmacophore can generate a vast array of changes in affinity and efficacy of ligands for the two opioid receptors (25-28). We find that more than 40% of the studied Dmt-Tic analogues display varying degrees of inverse efficacy for the DOP receptor, but act as partial or full agonists for the MOP receptor. This reversal of efficacy appears to depend on the greater constitutive activity of the DOP receptor compared to MOP. In fact, the maximal levels of absolute coupling for most ligands (i.e., the net BRET over the GDP baseline) are remarkably similar at the two receptors. The analysis of the data suggests a new model of receptor constitutive activation. According to such a view, constitutive activation of the receptor results from the intramolecular lessening of a constraint that all ligands must oppose to stabilize the ligand-bound receptor-G protein complex.
EXPERIMENTAL PROCEDURES
Reagents and Drugs  Cell culture media, reagents, and fetal calf serum were from Invitrogen; restriction enzymes from New England Biolabs; coelenterazine and bisdeoxycoelenterazine from Biotium Inc.; DADLE from Bachem; ICI 174,864 from Tocris; GDP (Tris Salt) from Sigma-Aldrich. All DMT-Tic analogues were synthesized as reported (26) (27) (28) . Their structures and abbreviations are listed in Supporting information, table s1 Cells and membranes  Preparation of retroviral vectors coding for Rluc-tagged human MOP and DOP receptors and RGFP-fused Gβ1 or -arrestin 2, and the transduction of SH-5YSY human neuroblastoma cells were described previously (22) . Cells were grown in a 1:1 mixture of Dulbecco's modified Eagle's medium and F-12, with 10% (v/v) fetal calf serum, 100 μg/ml hygromycin B and 400 μg/ml G418 in a humidified atmosphere of 5% CO 2 at 37°C. Enriched membranes from transfected cells were obtained by differential centrifugation (22) and stored in aliquots at -80 °C before use. BRET measurement and data analysis  BRET signals were measured and analyzed as previously described (20) (21) (22) . Receptor/Gβ1 interactions were measured in 96-well white plastic plates (Packard Opti-plate) using membrane preparations (5μg of proteins) in a total volume of 100 μl PBS; receptor/-arrestin 2 interactions were measured in intact cell monolayers. All ligands were tested using 8 log-spaced concentrations and in each assay microplate concentration-response curves for the nucleotide GDP and for the full agonist [D-Ala ]enkephalin (DADLE) were included, to assess respectively the level of zero and maximal receptor activation. At concentrations  100 M several Dmt-Tic analogues produced detectable inhibition of Rluc activity (measured as in (22)). Therefore, concentrations greater than 10 M were avoided. Curves representing the change of BRET ratio as a function of ligand concentration were first analyzed by nonlinear curve fitting with the general logistic function (29):
where x is ligand concentration; a and d, the curve asymptotes; c is the ligand concentration yielding halfmaximal BRET change; and b is the slope factor at c (with positive or negative sign, for agonists or inverse agonists and GDP One is the position of the carboxylic group in the "tripeptide" series of Tic-Dmt analogues. Common motif in this class of ligands is the presence of different amino acids extending the C-terminal of the Tic residue (Table 1 and Fig. 3a) . The replacement of Glu-NH 2 with Gln-COOH (i.e., the transfer of the carboxylate anion from the side chain to the peptide backbone), results in a dramatic reduction of IA, which converts a strong partial agonist into an inverse agonist. A similar reduction is observed in the pair of peptides that are extended with the corresponding D-amino acids. Likewise, a corresponding pattern (neutral antagonist becoming inverse agonist) occurs on replacing Asp-NH 2 with Asn-OH (Fig. 3a) . Thus, the location of the C-terminal carboxylate plays a fundamental role in the efficacy of the ligands for the DOP receptor. Since the IA of such ligands could not be measured in MOP receptors, a comparative assessment of the effect of this modification cannot be made. The second modification is the dimethylation of the Dmt amino group. Six pairs of ligands consisting of aminofree and dimethylated versions of the same molecules allowed full concentration-response curves analysis, and thus the comparison across receptors. Alkylation reduced IA in both receptors. However, given the difference in spontaneous coupling, this decrease generated inverse agonism in DOP but only reduced the extent of agonism in the MOP receptor (Table 1) .
To analyze the effect, we plot DOP vs. MOP ligand IA values ( fig. 3b ). In this graph, the vectors tracing the distance in activity between unsubstituted and substituted analogues measure the joint variation of IA caused by ligand modification in both systems. They have different lengths, because dimethylation has a different effect on each peptide, but the slopes are similar and roughly parallel to the line of perfect correlation. This means that both direction and magnitude of the loss of IA caused by Nmethylation are well conserved in DOP and MOP. Therefore, the modification produces an identical reduction of efficacy (presumably acting through an identical mechanism) in both. Yet, if we evaluate the variation with respect to the level of constitutive coupling, the same loss of efficacy converts agonists into inverse agonists at DOP but only reduces agonism at MOP receptor. The effect of methylation on the pEC 50 of the ligands was instead divergent in the two receptors. The alkylation increased potency in 5 out of 6 ligands at DOP receptor, but produced either reductions or enhancements of pEC 50 at MOP receptors (Fig. 3c ). These data are consistent with the previous findings that N-alkylation of the Dmt-Tic pharmacophore increases the binding affinity for the DOP receptor (25).
The relationship between maximal coupling and the shift of GDP apparent affinity ─ We used a more precise approach to asses ligands efficacy at MOP and DOP receptors. There is negative cooperativity between ligand and GDP in GPCR systems. Thus, efficacy can be deduced from the effect that the ligand exerts on the apparent inhibition constant (Ki) of GDP. Using ligands covering the full range of efficacy, we examined the relationship between ligands IA and apparent Ki of GDP (plotted as negative log pKi) in both receptors. These curves are very similar in DOP and MOP (Fig. 4d ). In the low ligands IA range, large differences in coupling correspond to minimal changes of pKi; vice versa in the high range (Fig. 4d ). This curvilinear shape is due to the dual components of the free-energy change that underlies Ki. One -related to the binding interaction -is constant. The other -reflecting cooperativity -varies with ligand efficacy. Thus, at lower ligands IA (small cooperative effects) changes in Ki barely exceed the experimental error, but at greater values the differences become increasingly visible. Note that the changes in GDP pKi caused by empty receptors are well aligned with those inducced by ligands, indicating that the level of coupling in the unbound receptor is predictable from those observed in ligand-bound receptors. For a system consisting of two ligands interacting at different sites of the same protein complex, the shift in one ligand apparent affinity caused by saturating concentrations of the second provides a direct measure of the free energy-coupling existing between the two binding processes (16) . We computed such coupling constants (i.e. net differences in GDP pKi between absence and presence of ligand) for peptides with the same IA in both receptors. Plotting such values in MOP vs. DOP receptor yields a linear relationship with unitary slope and nonzero intercept (Fig. 4e) . The unit slope indicates that for any given change of ligand structure there are identical changes of allosteric coupling (efficacy) in the two receptor/G protein systems. But the upward shift of the line on the y-axis indicates that all free-energy coupling values in the DOP receptor are uniformly reduced by a constant factor compared to the MOP receptor. The size of this shift (1 unit of freeenergy on the RT scale) is equivalent to the difference in GDP Ki between the two empty receptors ( fig. 4c ).
Model of constitutive activation ─ The overall pattern of constitutive activation and inverse agonism documented in this study is in contrast with the prediction of models such as the ternary complex model (TCM) (14) and/or the extended (ETC) (5, 15) or cubic (CTC) (17) models.
Assuming that DOP and MOP only differ in costitutive coupling and that Dmt-Tic with equal IA have identical molecular efficacies, we computed how that pattern should be predicted according to the TCM ( fig. 5a and eq.1 in Appendix). This "TCM-fitting" analysis shows that a difference of constitutive activity (i.e. M' DOP >M' MOP ) cannot coexist with equal levels of maximal activity, if the molecular efficacies of the ligands are identical in the two receptors (i.e. ' iDOP =' iMOP ). Moreover a change of constitutive activation cannot alter the rank of ligands intrinsic activities: e.g., inverse agonists inhibit spontaneous association in both the highly constitutively active and low constitutively active receptor, even if in the latter it might be difficult to quantify the effect. (see Appendix and fig.5a ). The same analysis indicates that to observe equal IA values the molecular efficacy of the ligands for DOP should be uniformly reduced by a quota of free-energy which is exactly equivalent to the difference in G protein binding affinity between DOP and MOP receptors ( fig.  5bc and Appendix). Thus, both theoretical analysis ( We developed a different extension of the TCM model, which is capable to explain the phenomenology reported in this study (see Appendix). In former models constitutive activity depends on the equilibrium between active and inactive forms of the receptor. This equilibrium is cooperatively linked to ligand binding in the same way as it is to the association between receptor and G protein.
Thus, for any change in magnitude of that equilibrium, constitutive and ligand-induced complexes are invariantly ordered on the coupling scale (15) . In the present model, however, the allosteric transition is conceived as a change in energy state of the system, which may occur in either or both reacting proteins. This represents the energy cost of the transition from spontaneously occurring to ligandcontrolled multiprotein complexes, and is linked by strong negative cooperativity to every ligand binding process. Ligands must restrain spontaneous coupling in order to drive the system to the ligand-bound associated form. Thus constitutive and ligand-driven coupling are competitive non converging paths that lead to activation of the system (see Appendix).
The simulations in figs. 6 and 7 show how the sole enhancement of the equilibrium for this intramolecular transition, without any other change in ligand-dependent parameters, can generate a pattern of constitutive activation which reproduces all the phenomenology described in this paper. Identical results with minor adjustments in parameter values can be generated using all 3 versions of the model discussed in Appendix (data not shown). To challenge the model an experiment was first predicted "in silico". If on adding a suitable concentration of GDP to the high constitutive active subtype we equalize the levels of spontaneous coupling in the two receptors, the correspondence of ligand intrinsic activities should be lost (Fig. 7a) . We executed the same experiment in real membranes using a subset of ligands with similar intrinsic activities (Fig. 7b) . Simultaneous fitting of concentration response curves obtained in parallel MOP and DOP membrane assays confirm that the ligands share indistinguishable IA values in the receptors; but this symmetry is disrupted upon addition of 200 nM GDP to DOP, which lowers its constitutive activity to a level closer to that of MOP (Fig. 7b) . Consequently, the linear relationship between ligands IA in the two receptors is converted to hyperbolic ( fig. 7c ).
DISCUSSION
In this study we compared the activity of a congeneric series of ligands for wild-type DOP and MOP receptors using a BRET-based measurement of receptor-G protein interaction in membranes. Like GTPS binding, this assay provides a signal that is directly related to receptor-G protein association, but brings two additional advantages:
The ability to assess both receptor-G protein association and the apparent affinity of nucleotides, and the capacity to measure receptor-G protein coupling of both ligandbound and unbound receptor. , which is capable to explain the phenomenology reported in this study. Two interesting mechanistic implications can be drawn from this modeling analysis. First, the nature of linkage between ligand-dependent and independent activation. Unlike the concerted shift towards a common allosteric conformation of previous models, this alternative view predicts that all ligands exert negative cooperativity against the process of constitutive activation. Therefore, no ligand-bound state of the system can be energetically equivalent to the ligand-free state. This agrees with a recent single-molecule force-spectroscopy study of  2 adrenoceptors bound to ligands of differing efficacies. As shown there, no ligand-bound receptor form can exactly match the energetic, kinetic, and mechanical pattern of the empty receptor (32). Second, the dual allosteric process underlying molecular efficacy. There is a ligand-specific cooperative effect that stabilizes the receptor-transducer complex (), but also a shared anticooperative "binding effect" () that every ligand exerts in raising the free-energy barrier for spontaneous coupling. This adds to and may cancel the free-energy change of the first. Therefore, a ligand with unchanged ability to stabilize the receptor-transducer complex can show agonism in a low intrinsically coupled receptor but inverse agonism when a reduction of the energy barrier generates constitutive coupling. It follows that the direction in which ligands steer basal receptor activity is not a reliable indicator of molecular efficacy. We don't know how prevalent the mechanism of inverse agonism observed here might be among GPCRs.
Of the two additional types of inverse agonists we tested (table 1) , the naltrexone derivative BTNX displayed close IA values in the two receptors, with the blend of DOP inverse agonism / MOP partial agonism that is typical of Dmt-Tic peptides. But the pentapeptide ICI-174864, even if the E max value at MOP was unmeasurable, clearly showed a different trend, suggesting a true reversal of molecular efficacy in the two receptors. Thus, it is possible that the phenomenon described in this paper depends on a particular way in which certain structural classes of ligands interact with the binding pocket. Obviously further studies on additional congeneric series of ligands in several GPCRs will be required. However, the anticooperativity that opposes ligand-induced to spontaneous coupling, which the behaviour of Dmt-Tic ligands unveils, is likely to depict a general feature of GPCRs, and may bring more insight in the functional chemistry of these molecules. fig. 8 ) with 3 independent parameters: two affinity constants K' and M' govern the formation of HR and RG complexes in the absence of G or H, while an allosteric constant ' describes the thermodynamic coupling between H and G binding to R (the prime symbol stands for effective constants as it will be explained later). For each receptor/G protein system, ' encapsulates the molecular efficacy of ligands, and M' controls constitutive coupling. Let's consider 2 receptors (R 1 , R 2 ) that differ in affinity for a common G protein (i.e. 
APPENDIX

Agonism and inverse agonism in the ternary complex model (TCM).-The TCM depicts the interactions among ligand (H), receptor (R) and G protein (G) (
(Where, i and j label different ligands and receptors, respectively; t total reactant concentration). As shown in fig. 5a , given:
, R t DOP = R t MOP , G t =constant, and 
. Written in log form this yields: ) for the formation of RG complex by the two empty receptors ( fig. 5bc ). This analysis implies a thermodynamic linkage between RG affinity (M') and ligand efficacy ('), so that a change in the first can uniformly change the second. Such a covariance of M' and ' cannot be defined within the macroscopic framework of the TCM.
Minimal models that link apparent ligand efficacy to constitutive activity -The 3 parameters of the TCM must be considered apparent or "effective" constants. Although both K' and M' include an intra-and inter-molecular free-energy component, they are defined as pure bimolecular associations because the intra-molecular contribution is not experimentally measurable (33). Also, the ligand-induced perturbation ' can only be appraised as "additive" free-energy of the bimolecular interactions. In this sense the 3 parameters are independent. If however we find covariance between 'and M' (as we do here), it means that the intra-molecular perturbation underlying RG binding does not simply adds to, but interacts with ligand-induced perturbations. In previous work (15) a different covariance between 'and K' was made explicit in the model assuming an allosteric switch of the receptor between functional states, since the experimental readout in those studies was the signaling activity of receptor mutants. In this study we measure the assembly of R-G complexes in the absence or presence of ligands or nucleotide. Moreover, the linkage between 'and M'
shows as an equal energy cost that affects all ligandinduced perturbations regardless of their entity. Thus, to make explicit this intrinsic link we postulate an intramolecular change between two different energy states (S 1 and S 2 ) controlled by a first-order constant J. Since this transition can occur with equal probability in R, G, or RG, we analyzed in parallel all 3 possible versions of the model, and named them accordingly: ACM (allosteric complex model), ARM (allosteric receptor model) and AGM (allosteric G protein model) ( fig. 8) . The interaction among the two protein species (R and G), each binding a distinct ligand (peptide H and nucleotide N), leads to the formation of the coupled forms with and without ligands (i.e. the BRET-emitting species) and depends on the J-driven state transition (S 1  S 2 ) and its cooperative linkage to the binding events. Although all 3 model versions describe quite complex reaction schemes, we use two simplifications to analyze how parameter configurations predicts the BRET response. First, all parameters in the 3 versions can be reduced by exact functions to the "effective" parameters 'and M' of a "macroscopic" TCM equivalent scheme; thus, we can use this approach to analytically define which variations in model parameters lead to a joint variation of 'and M'. fig.8) , the relationship between model parameters and the effective parameters of the equivalent TCM are:
... eqs.3
As shown before in eq. 2, the condition to maintain equal ligands IA across receptors is: 1 fig. 8 ). Since we know that guanine nucleotides (both GTP and GDP) disrupt the stability of the RG complex (34),  must lead to a reduction of the effective affinity M'( <1). In the model, however, both J and M contribute to the value of M'. Thus, to reduce M' the binding of N could be negatively coupled either to the state transition (S 1  S 2 ) or to the intermolecular association R G. We reasoned that the correspondence of ligands IA between receptors would be preserved in the first case but not in the second. Based on the effects of GDP shown in figure 7b, we choose the second option. This means that GDP can change via cooperativity () the stability of the RG complex (just like H does via ), but cannot directly alter the state transition of the system.
Simulations of experimental data. -Simulations according to the 3 model versions were made using a previously described (35,36) numerical algorithm (a Microsoft Excel file with embedded code that allows to explore the models is freely available upon request from H.O.O.). Parameters were varied according to the rules discussed above and chosen to best fit the experimental data. The difference in constitutive coupling between DOP and MOP was emulated by increasing J in ACM or  in ARM and AGM. This is an arbitrary and inconsequent choice, since the values of J and  can be reciprocally scaled as long as eqs. 5 are obeyed. To simplify,  was kept constant across ligands in the shown simulations, although we found that small random variations in  can produce similar scatter in the relation of ligands IA between receptors as we measured experimentally ( fig.1d) . In summary, the sole increase of  or J in DOP with no change of other parameters can perfectly "fit" all the observed phenomenology: apparent reversal of ligands IA between receptors, disrupted by GDP ( fig. 7 ) and the uniform decrease of free-energy coupling values for ligand and GDP measured in DOP receptor ( fig. 6 ).
Relationship with previous models. -The model presented here is very similar or even mathematically identical (e.g. the ARM version in fig.8 ) to previous extensions of the TCM (15,17,37). The major difference is the intrinsic state transition, which goes in concert with ligands-induced perturbations in ETC (15) or CTC (17) but it is opposed by ligands in this model. Consequently, ETC or CTC cannot explain the M' and ' covariance discussed here, nor can this model account for the K' and ' covariance observed there. Rather than a contradiction, this indicates that change in function and change in energy state of the system cannot be described with the same allosteric transition. A more general theoretical framework to interpret the full repertoire of allosteric receptor behavior is needed. BRET studies on constitutively activated receptor mutants are under way in our lab, and may help us to make a step forward in that direction.
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